Each year, the Endpoints newsroom places bets on the 11 private biotech companies that we think are the most promising, the most cutting-edge — and would leave the biggest crater behind if things go belly-up. Wednesday on Post-Hoc Live, we’ll share a behind-the-scenes look at how we pick the Endpoints 11, tease what types of companies we focused on this year, and look back at what’s happened to the 66 startups we’ve had on the list so far. And we’ll see you on September 18, when we unveil this year’s list in Boston. Reserve your spot here: https://events.endpoints.news/eleven25